{
    "nctId": "NCT02589977",
    "officialTitle": "Myocardial Perfusion, Oxidative Metabolism, and Fibrosis in HFpEF",
    "inclusionCriteria": "* estimated glomerular filtration rate (eGFR) \\> 60 ml/min\n* preserved left ventricular ejection fraction (\\>= 50%) on echocardiography\n* Must have minimum age of 50 Years\n* Must have maximum age of 75 Years",
    "exclusionCriteria": "* coronary artery disease\n* diabetes mellitus\n* contraindications to cardiac magnetic resonance imaging (CMR)\n* weight \\>350 lbs\n* inability to lie flat for imaging\n* anemia\n* contraindications to regadenoson or aminophylline\n\nHEALTHY\n\nInclusion criteria:\n\n* normal cardiac structure and function on echocardiography\n* BP \\< 140/90\n\nExclusion criteria:\n\n* known cardiovascular disease, cardiac risk factors or use of cardiac medications\n\nHYPERTENSIVE\n\nInclusion criteria:\n\n* history of BP \\>140/90\n* 1 or more antihypertensive medications\n* LV ejection fraction (LVEF) at least 50%\n* current BP \\< 160/90\n\nExclusion criteria:\n\n* known cardiovascular disease or risk factors aside from hypertension or use of cardiac medications\n\nHFpEF\n\nInclusion criteria:\n\n* physician-confirmed diagnosis of HF\n* symptomatic HF\n* LVEF at least 50%\n* elevated LV filling pressure by catheterization, echocardiographic criteria or B-type-natriuretic peptide \\> 100\n* current BP \\< 160/90\n\nExclusion criteria:\n\n* prior history of LVEF below 50%\n* acute decompensated HF\n* moderate or greater valvular disease\n* significant cardiac arrhythmias\n* pericardial disease\n* congenital heart disease\n* primary pulmonary hypertension"
}